:

Cheng Xue1, Jiayi Lv1, Bo Yang2

  • 1Division of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University (Naval Medical University), Shanghai 200003, China.

概括

像CRISPR-Cas9这样的基因编辑技术为治疗多囊病 (PKD) 提供了新的希望. 这些先进疗法在ADPKD和ARPKD的临床前和早期临床研究中显示出有前途.